Drain and clot-dissolving medicine for severe aneurysm bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- This must be your first time having a bleeding stroke from a brain aneurysm.
- You have not had brain surgery (craniotomy) before this event.
- Your aneurysm was treated (coiled or clipped) within 48 hours of the bleeding.
- Your doctors will assess your consciousness level (Hunt-Hess grade III, IV, or V) and bleeding severity.
- You cannot be pregnant or allergic to the study drug (urokinase).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.
This study tests whether nadroparine (a blood-thinning medicine) can improve outcomes after a type of brain bleed called subarachnoid hemorrhage. It focuses on people who have had a brain aneurysm treated with a procedure soon after the bleed.
This trial tests a specific way of treating a brain aneurysm that has caused a severe bleed (subarachnoid hemorrhage). Instead of coiling the whole aneurysm, doctors will only coil the dome part. The goal is to see if this simpler approach helps patients who are very sick from the bleeding.
This trial tests whether the clot-busting drug urokinase can help people who have had an ischemic stroke (a stroke caused by a blood clot). The goal is to dissolve the clot and improve recovery, as long as treatment starts within 6 hours of the first symptoms.
This trial tests whether a targeted (stereotactic) procedure to remove deep brain bleeding, combined with a medicine called urokinase, is safer and works better than standard care. It focuses on people whose bleeding is in the deep brain and who are able to undergo surgery within a specific time window.
This study tests whether a clot-busting drug called pro-urokinase can help people with a stroke in the back of the brain when given later than usual (4.5 to 9 hours after symptoms start). The goal is to see if it improves recovery and reduces disability.
Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.